Nobuyuki Ae

Title: Nobuyuki Ae: Innovator in Pharmaceutical Chemistry

Introduction

Nobuyuki Ae is a prominent inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic potential. With a total of 3 patents to his name, Ae's work focuses on innovative solutions for neurological disorders.

Latest Patents

One of his latest patents is for a tricyclic indole-2-carboxylic acid compound used as an NMDA receptor antagonist. This invention provides novel tricyclic indole-2-carboxylic acids that exhibit potent NMDA receptor antagonistic activity. Another notable patent involves tricyclic quinoxalinedione derivatives, which are represented by a specific chemical formula. These derivatives have potential applications in various therapeutic areas.

Career Highlights

Nobuyuki Ae is currently associated with Sumitomo Pharmaceuticals Company Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating compounds that may lead to new treatments for neurological conditions.

Collaborations

Ae collaborates with esteemed colleagues, including Ryu Nagata and Norihiko Tanno. Their combined expertise enhances the innovative capacity of their projects and contributes to the advancement of pharmaceutical research.

Conclusion

Nobuyuki Ae's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for new therapeutic options in treating neurological disorders.